In a glioma model, release of soluble CD40 from platelets has been reported; this is a known inhibitor of regulatory T cell recruitment, which promotes an immunosuppressive microenvironment and ultimately a pro-tumor milieu (40). The gene discussed is CD40; the disease is central nervous system cancer.